Patents by Inventor Kevin Wildenhaus

Kevin Wildenhaus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220199225
    Abstract: A computing device may be configured for user interaction with specific timing mechanisms and access rules that may improve a user's preparedness for and ultimate success with a behavior change effort, such as smoking cessation, healthy eating, and/or behaviors to promote a healthy pregnancy. The computing device may include a processor that executes an enforcement module on the condition that both a user attempts to access a first content-interaction module between the first end time on a first scheduled date and a second start time on a second scheduled date and the user did not attempt to access the first content-interaction module between the first start time on the first scheduled date and the first end time on the first scheduled date. The enforcement module may indicate that the first content-interaction module is no longer available and that a second content-interaction module will become available on the second scheduled date.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 23, 2022
    Applicant: McNeil AB
    Inventors: Kevin Wildenhaus, Sophie Edgar, Justin Mellinger, Ming Dong, Desislava Ivanova, Danielle Giuseffi
  • Publication number: 20210178184
    Abstract: A method comprising: a) placing a light-emitting portion of a device comprising a near infrared LED against an eyelid of a person having a brain in a location between an upper portion of an eye and a corresponding eye socket of the person, b) moving the device posteriorly so that at least a portion thereof sits within a portion of an outer region of the eye socket, and c) actuating the LED to deliver near infrared light to an orbitofrontal cortex of the person.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 17, 2021
    Applicant: Janssen Pharmaceutica NV
    Inventors: Thomas M. DiMauro, Kevin Wildenhaus, John Pracyk
  • Patent number: 10960224
    Abstract: A device adapted to deliver red/NIR light through an eyelid of a patient, the device comprising: a) a nose bridge, b) a first orbital rim adapted to encircle a first eye, wherein the first orbital rim is attached to the bridge, and c) a red/NIR LED attached to the rim.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: March 30, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Thomas M DiMauro, Kevin Wildenhaus, John Pracyk, Michael Luedtke
  • Patent number: 10614724
    Abstract: Systems and methods for wellness, health, and lifestyle planning, tracking, and maintenance are provided. In general, the systems and methods described herein can allow a person to manage his/her wellness, health, and lifestyle using a convenient system that can help the person plan strategies for improving and/or maintaining his/her wellness, health, and lifestyle and/or that can help the person track his/her compliance with the strategies. In an exemplary embodiment, the system can be configured to provide recommendations of activities to the person that can positively affect the person's wellness, health, and lifestyle. The recommendations can be tailored to each individual user of the system such that different people can receive different recommendations.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: April 7, 2020
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Steve Catani, Jeffrey Matthes, Janeta Nikolovski, Richard Bedrosian, Amy Michelle Bucher, Benjamin C. Wiegand, Juan L. Navia, Kevin Wildenhaus, Sanjay Mandloi
  • Patent number: 10064417
    Abstract: A method of cleaning mother's milk, involving ex vivo contacting mother's milk having an initial concentration of an antidepressant therein with a solid substrate (preferably a porous substrate) adapted to remove the antidepressant from the milk to produce a cleansed milk product having a reduced concentration of the antidepressant.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: September 4, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Thomas M DiMauro, Kevin Wildenhaus
  • Publication number: 20180193664
    Abstract: A device adapted to deliver red/NIR light through an eyelid of a patient, the device comprising: a) a nose bridge, b) a first orbital rim adapted to encircle a first eye, wherein the first orbital rim is attached to the bridge, and c) a red/NIR LED attached to the rim.
    Type: Application
    Filed: December 13, 2017
    Publication date: July 12, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Thomas M DiMauro, Kevin Wildenhaus, John Pracyk, Michael Luedtke
  • Publication number: 20180193660
    Abstract: An aesthetically pleasing intranasal NIR/red light emitting device, wherein the device is a) secured in a first nostril by a spring clip securely contacting the inner surface of the opposite nostril, or b) secured in a first nostril by a retaining element (such as an adhesive) adapted to containing substantially only the inner surface of the first nostril.
    Type: Application
    Filed: October 25, 2017
    Publication date: July 12, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Thomas M. DiMauro, Kevin Wildenhaus, John Pracyk, Michael Luedtke
  • Publication number: 20180050005
    Abstract: A method of treating a mother having postpartum depression, comprising administering to the mother a composition comprising a plurality of mixed self-assemblies comprising: i) at least 50 wt % of a soyasaponin, and ii) allopregnanolone.
    Type: Application
    Filed: November 17, 2016
    Publication date: February 22, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Thomas M DiMauro, Kevin Wildenhaus
  • Publication number: 20180050107
    Abstract: Provided herein are compositions comprising neurosteroids and saponins, methods of making said compositions, and methods of utilizing said compositions to treat or prevent perinatal depression (PND) in a subject in need thereof.
    Type: Application
    Filed: August 15, 2017
    Publication date: February 22, 2018
    Applicant: Janssen Pharmaceutica NV
    Inventors: Thomas M DiMauro, Kevin Wildenhaus, Michael J Fevola, Tobias Johannes Fuetterer
  • Publication number: 20170164630
    Abstract: A method of cleaning mother's milk, involving ex vivo contacting mother's milk having an initial concentration of an antidepressant therein with a solid substrate (preferably a porous substrate) adapted to remove the antidepressant from the milk to produce a cleansed milk product having a reduced concentration of the antidepressant.
    Type: Application
    Filed: September 23, 2016
    Publication date: June 15, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Thomas M DiMauro, Kevin Wildenhaus
  • Publication number: 20150364057
    Abstract: Systems and methods for wellness, health, and lifestyle planning, tracking, and maintenance are provided. In general, the systems and methods described herein can allow a person to manage his/her wellness, health, and lifestyle using a convenient system that can help the person plan strategies for improving and/or maintaining his/her wellness, health, and lifestyle and/or that can help the person track his/her compliance with the strategies. In an exemplary embodiment, the system can be configured to provide recommendations of activities to the person that can positively affect the person's wellness, health, and lifestyle. The recommendations can be tailored to each individual user of the system such that different people can receive different recommendations.
    Type: Application
    Filed: June 15, 2015
    Publication date: December 17, 2015
    Inventors: Steve Catani, Jeffrey Matthes, Janeta Nikolovski, Richard Bedrosian, Amy Michelle Bucher, Benjamin C. Wiegand, Juan L. Navia, Kevin Wildenhaus, Sanjay Mandloi